ARTICLE | Distillery Therapeutics
Cancer
April 18, 2017 2:22 PM UTC
Patient sample, cell culture, and mouse studies suggest inhibiting BCL6 could help treat glioblastoma multiforme (GBM). In patients, high tumor levels of BCL6 were associated with poor survival. In GB...
BCIQ Company Profiles
BCIQ Target Profiles